Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
Por um escritor misterioso
Descrição
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and
APExBIO - MI-2 (hydrochloride) menin-MLL interaction inhibitor
IJMS, Free Full-Text
RCSB PDB - 4GPQ: Structural insights into inhibition of the
Molecular mechanisms of MLL-associated leukemia
A molecular switch between mammalian MLL complexes dictates
Menin-MLL inhibitor MI-2 Epigenetic Reader Domain Inhibitor
Leukemogenesis via aberrant self‐renewal by the MLL/AEP‐mediated
Development of second-generation menin- MLL inhibitors. (A
Challenges and opportunities in targeting the menin–MLL
PDF] Menin inhibitor MI-3454 induces remission in MLL1-rearranged
APExBIO - MI-2, Menin-MLL Inhibitor
Structure, function and inhibition of critical protein–protein